Role of matrix metalloproteinases in abdominal aortic aneurysms

Annals of the New York Academy of Sciences

Volumn 800, Issue , 1996, Pages 157-174

  Thompson, Robert W ^a,b   Parks, William C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Section of Vascular Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TETRACYCLINE DERIVATIVE;

ABDOMINAL AORTA ANEURYSM; ARTICLE; ELASTOLYSIS; ENZYME REPRESSION; HUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

RODENTIA;

EID: 0030472789     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb33307.x     Document Type: Article

References (93)

1. ERNST, C. B. 1993. Abdominal aortic aneurysm. N. Engl. J. Med. 328: 1167-1172.
2. ZATINA, M. A., C. K. ZARINS, B. L. GEWERTZ & S. GLAGOV. 1984. Role of medial lamellar architecture in the pathogenesis of aneurysms. J. Vasc. Surg. 1: 442-448.
3. CAMPA, J. S., R. M. GREENHALGH & J. T. POWELL. 1987. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 65: 13-21.
4. GANDHI, R. H., E. IRIZARRY, J. O. CANTOR, S. KELLER, G. B. NACKMAN, V. J. HALPERN, K. M. NEWMAN & M. D. TILSON. 1994. Analysis of elastin cross-linking and the connective tissue matrix of abdominal aortic aneurysms. Surgery 115: 617-620.
5. HOLMES, D. R., S. LIAO, W. C. PARKS & R. W. THOMPSON. 1995. Medial neovascularization in abdominal aortic aneurysms: A histopathologic marker of aneurysmal degeneration with pathophysiologic implications. J. Vasc. Surg. 21: 761-772.
6. HE, C. M. & M. R. ROACH. 1994. The composition and mechanical properties of abdominal aortic aneurysms. J. Vasc. Surg. 20: 6-13.
7. LÓPEZ-CANDALES, A., D. R. HOLMES, S. LIAO, M. J. SCOTT, S. A. WICKLINE & R. W. THOMPSON. 1996. Medial degeneration in human abdominal aortic aneurysms: Loss of vascular smooth muscle cells associated with apoptosis and increased expression of p53. Submitted.
8. KOCH, A. E., G. K. HAINES, R. J. RIZZO, J. A. RADOSEVICH, R. M. POPE, P. G. ROBINSON & W. H. PEARCE. 1990. Human abdominal aortic aneurysms: Immunophenotypic analysis suggesting an immune-mediated response. Am. J. Pathol. 137: 1199-1213.
9. BROPHY, C. M., J. M. REILLY, G. J. WALKER SMITH & M. D. TILSON. 1991. The role of inflammation in nonspecific aneurysm disease. Ann. Vasc. Surg. 5: 229-233.
10. DOBRIN, P. B., W. H. BAKER & W. C. GLEY. 1984. Elastolytic and collagenolytic studies of arteries: Implications for the mechanical properties of aneurysms. Arch. Surg. 119: 405-409.
11. MENASHI, S., J. S. CAMPA, R. M. GREENHALGH & J. T. POWELL. 1987. Collagen in abdominal aortic aneurysm: Typing, content, and degradation. J. Vasc. Surg. 6: 578-582.
12. RIZZO, R. J., W. J. MCCARTHY, S. N. DIXIT, M. P. LILLY, V. P. SHIVELY, W. R. FLINN & J. S. T. YAO. 1989. Collagen types and matrix protein content in human abdominal aortic aneurysms. J. Vasc. Surg. 10: 365-373.
13. DOBRIN, P. B. & R. MRKVICKA. 1994. Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc. Surg. 2: 484-488.
14. WEBSTER, M., C. E. MCAULEY, D. L. STEED, D. D. MILLER & C. H. EVANS. 1991. Collagen stability and collagenolytic activity in the normal and aneurysmal human abdominal aorta. Am. J. Surg. 161: 635-638.
15. KONTUSAARI, S., G. TROMP, H. KUIVANIEMI, et al. 1990. A mutation in the gene for type III procollagen (COL3A1) in a family with aortic aneurysms. J. Clin. Invest. 86: 1465-1473.
16. SUPERTI-FURGA, A., B. STEINMANN, F. RAMIREZ & P. H. BYERS. 1989. Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV. Hum. Genet. 82: 104-108.
17. MCKUSICK, V. A. 1991. The defect in Marfan syndrome. Nature 352: 279-281.
18. TROMP, G., Y. WU, D. J. PROCKOP, S. L. MADHATHERI, C. KLEINERT, J. J. EARLEY, J. ZHUANG, O. NORRGARD, R. C. DARLING, W. M. ABBOTT, C. W. COLE, P. JAAKKOLA, M. RYYNANEN, W. H. PEARCE, J. S. T. YAO, K. MAJAMAA, S. N. SMULLENS, Z. GATALICA, R. E. FERRELL, S. A. JIMENEZ, C. E. JACKSON, V. V. MICHELS, M. KAYE & H. KUIVANIEMI. 1993. Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of type III procollagen are an infrequent cause of aortic aneurysms. J. Clin. Invest. 91: 2539-2545.
19. ANIDJAR, S. & E. KIEFFER. 1992. Pathogenesis of acquired aneurysms of the abdominal aorta. Ann. Vasc. Surg. 6: 298-305.
20. WHITE, J. V., K. HAAS, S. PHILLIPS & A. J. COMEROTA. 1993. Adventitial elastolysis is a primary event in aneurysm formation. J. Vasc. Surg. 17: 371-381.
21. TILSON, M. D. & K. M. NEWMAN. 1994. Proteolytic mechanisms in the pathogenesis of aortic aneurysms. In Aneurysms: New Findings and Treatments. J. S. T. Yao & W. H. Pearce, Eds.: 3-10. Appleton & Lange. East Norwalk, CT.
22. BUSUTTIL, R., A. M. ABOU-ZAMZAM & H. I. MACHLEDER. 1980. Collagenase activity of the human aorta: A comparison of patients with and without abdominal aortic aneurysms. Arch. Surg. 115: 1373-1378.
23. BUSUTTIL, R., H. RINDERBRIECHT, A. FLECHER & C. CARNACK. 1982. Elastase activity: The role of elastase in aortic aneurysm formation. J. Surg. Res. 32: 214-217.
24. COHEN, J. R., C. MANDELL & L. WISE. 1987. Characterization of human aortic elastase found in patients with abdominal aortic aneurysms. Surg. Gynecol. Obstet. 165: 301-304.
25. COHEN, J. R., I. SARFATI, D. DANNA & L. WISE. 1992. Smooth muscle cell elastase, atherosclerosis, and abdominal aortic aneurysms. Ann. Surg. 216: 327-332.
26. REILLY, J. M., G. A. SICARD & C. L. LUCORE. 1994. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. J. Vasc. Surg. 19: 865-872.
27. JEAN-CLAUDE, J., K. M. NEWMAN, H. LI, A. K. GREGORY & M. D. TILSON. 1994. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery 116: 472-478.
28. SCHNEIDERMAN, J., G. M. BORDIN, I. ENGELBERG, R. ADAR, D. SEIFFERT, T. THINNES, E. F. BERNSTEIN, R. B. DILLEY & D. J. LOSKUTOFF. 1995. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall: A possible mechanism for aneurysm expansion. J. Clin. Invest. 96: 639-645.
29. BROPHY, C. M., B. SUMPIO, J. M. REILLY & M. D. TILSON. 1991. Electrophoretic characterization of protease expression in aneurysmal aorta: Report of a unique 80 kDa elastolytic activity. Surg. Res. Commun. 10: 315-321.
30. REILLY, J. M., C. M. BROPHY & M. D. TILSON. 1992. Characterization of an elastase from aneurysmal aorta which degrades intact aortic elastin. Ann. Vasc. Surg. 6: 499-502.
31. VINE, N. & J. T. POWELL. 1991. Metalloproteinases in degenerative aortic disease. Clin. Sci. 81: 233-239.
32. HERRON, G. S., E. UNEMORI, M. WONG, J. H. RAPP, M. H. HIBBS & R. J. STONEY. 1991. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms: Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler. Thromb. 11: 1667-1677.
33. NEWMAN, K. M., Y. OGATA, A. M. MALON, E. IRIZARRY, R. H. GANDHI, H. NAGASE & M. D. TILSON. 1994. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler. Thromb. 14: 1315-1320.
34. NEWMAN, K. M., A. M. MALON, R. D. SHIN, J. V. SCHOLES, W. G. RAMEY & M. D. TILSON. 1994. Matrix metalloproteinases in abdominal aortic aneurysm: Characterization, purification, and their possible sources. Connect. Tissue Res. 30: 265-276.
35. NEWMAN, K. M., J. JEAN-CLAUDE, H. LI, J. V. SCHOLES, Y. OGATA, H. NAGASE & M. D. TILSON. 1994. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J. Vasc. Surg. 20: 814-820.
36. IRIZARRY, E., K. M. NEWMAN, R. H. GANDHI, G. B. NACKMAN, V. HALPERN, S. WISHNER, J. V. SCHOLES & M. D. TILSON. 1993. Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. J. Surg. Res. 54: 571-574.
37. THOMPSON, R. W., D. R. HOLMES, R. A. MERTENS, S. LIAO, M. D. BOTNEY, R. P. MECHAM, H. G. WELGUS & W. C. PARKS. 1995. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J. Clin. Invest. 96: 318-326.
38. MCMILLAN, W. D., B. K. PATTERSON, R. R. KEEN, V. P. SHIVELY, M. CIPOLLONE & W. H. PEARCE. 1995. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arteriocler. Thromb. Vasc. Biol. 15: 1139-1144.
39. FREESTONE, T., R. J. TURNER, A. COADY, D. J. HIGMAN, R. M. GREENHALGH & J. T. POWELL. 1995. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 15: 1145-1151.
40. MCMILLAN, W. D., B. K. PATTERSON, R. R. KEEN & W. H. PEARCE. 1995. In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta. J. Vasc. Surg. 22: 295-305.
41. MATRISIAN, L. M. 1990. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6: 121-125.
42. WOESSNER, J. F., JR. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2154.
43. BIRKEDAL-HANSEN, H., W. G. I. MOORE, H. K. BODDEN, L. J. WINDSOR, B. BIRKEDAL-HANSEN, A. DECARLO & J. A. ENGLER. 1993. Matrix metalloproteinases: A review. Crit. Rev. Oral Biol. Med. 4: 197-250.
44. BIRKEDAL-HANSEN, H. 1995. Proteolytic remodelling of extracellular matrix. Curr. Opin. Cell Biol. 7: 728-735.
45. SENIOR, R. M., G. L. GRIFFIN, C. J. FLISZAR, S. D. SHAPIRO, G. I. GOLDBERG & H. G. WELGUS. 1991. Human 92-kilodalton and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266: 7870-7875.
46. MURPHY, G., M. I. COCKETT, R. V. WARD & A. J. P. DOCHERTY. 1991. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: A quantitative comparison of the activities of 95 kDa and 75 kDa gelatinases, stromelysins-1 and -2 and puncuated metalloproteinase (PUMP). Biochem. J. 277: 277-279.
47. KATSUDA, S., Y. OKADA, Y. OKADA, K. IMAI & I. NAKANISHI. 1994. Matrix metalloproteinase-9 (92-kD gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin. Am. J. Pathol. 145: 1208-1218.
48. WARD, R. V., S. J. ATKINSON, P. M. SLOCOMDE, A. J. P. DOCHERTY, J. J. REYNOLDS & G. MURPHY. 1991. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim. Biophys. Acta 1079: 242-246.
49. BROWN, P. D., D. E. KLEINER, E. J. UNSWORTH & W. G. STETLER-STEVENSON. 1993. Cellular activation of the 72 kDa type IV procollagenase/TIMP2 complex. Kidney Int. 43: 163-170.
50. MONSKY, W. L., T. KELLY, C.-Y. LIN, Y. YEH, W. G. STETLER-STEVENSON, S. C. MUELLER & W.-T. CHEN. 1993. Binding and localization of Mr 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res. 53: 3159-3164.
51. STRONGIN, A. Y., I. COLLIER, G. BANNIKOV, B. L. MARMER, G. A. GRANT & G. I. GOLDBERG. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase: Isolation of the activated form of the membrane metalloproteinase. J. Biol. Chem. 270: 5331-5338.
52. SATO, H., T. TAKINO, Y. OKADA, J. CAO, A. SHINAGAWA, E. YAMAMOTO & M. SEIKI. 1994. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61-65.
53. WILL, H. & B. HINZMANN. 1995. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231: 602-608.
54. OKADA, A., J. P. BELLOCQ, N. ROUYER, M. P. CHENARD, M. C. RIO, P. CHAMBON & P. BASSET. 1995. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA 92: 2730-2734.
55. HALPERT, I., S. A. WICKLINE, J. D. ROBY, U. D. SIRES, T. N. WIGHT, H. G. WELGUS & W. C. PARKS. 1996. The role of proteoglycan (versican) cleavage by the metalloenzyme matrilysin in unstable atherosclerotic lesions in patients (abstract). J. Am. Coll. Cardiol. 27 (Suppl. A): 355A.
56. SHAPIRO, S. D., G. L. GRIFFIN, D. J. GILBERT, N. A. JENKINS, N. G. COPELAND, H. G. WELGUS, R. M. SENIOR & T. J. LEY. 1992. Molecular cloning, chromosomal localization, and bacterial expression of a murine macrophage metalloelastase. J. Biol. Chem. 267: 4664-4671.
57. SHAPIRO, S. D., D. KOBAYASHI & T. J. LEY. 1993. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268: 23824-23829.
58. BELAAOUAJ, A., J. M. SHIPLEY, D. K. KOBAYASHI, D. B. ZIMONJIC, N. POPESCU, G. A. SILVERMAN & S. D. SHAPIRO. 1995. Human macrophage metalloelastase: Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J. Biol. Chem. 270: 14568-14575.
59. SHIPLEY, J. M., R. L. WESSELSCHMIDT, D. K. KOBAYASHI, T. J. LEY & S. D. SHAPIRO. 1996. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl. Acad. Sci. USA. In press.
60. SENIOR, R. M., N. L. CONNELLY, J. D. CURY, H. G. WELGUS & E. J. CAMPBELL. 1989. Elastin degradation by human alveolar macrophages: A prominent role of metalloproteinase activity. Am. Rev. Respir. Dis. 139: 1251-1256.
61. KEEN, R. R., K. D. NOLAN, M. CIPPOLLONE, E. SCOTT, V. P. SHIVELY, J. S. T. YAO & W. H. PEARCE. 1994. Interleukin-1 beta induces differential gene expression in aortic smooth muscle cells. J. Vasc. Surg. 20: 774-784.
62. SUZUKI, K., J. J. ENGHILD, T. MORODOMI, G. SALVESEN & H. NAGASE. 1990. The activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29: 10261-10270.
63. SOUTHGATE, K. M., M. DAVIES, R. F. G. BOOTH & A. C. NEWBY. 1992. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem. J. 288: 93-99.
64. OKADA, Y., S. KATSUDA, Y. OKADA & I. NAKANISHI. 1993. An elastinolytic enzyme detected in the culture medium of human arterial smooth muscle cells. Cell Biol. Int. 17: 863-869.
65. GALIS, Z. S., M. MUSZYNSKI, G. K. SUKHOVA, E. SIMON-MORRISSEY, E. N. UNEMORI, M. W. LARK, E. AMENTO & P. LIBBY. 1994. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75: 181-189.
66. PAULY, R. R., A. PASSANITI, G. BILATO, R. MONTICONE, L. CHENG, N. PAPADOPOULOS, Y. A. GLUZBAND, L. SMITH, C. WEINSTEIN, E. G. LAKATTA & M. T. CROW. 1994. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ. Res. 75: 41-54.
67. LEE, E., D. E. VAUGHAN, S. H. PARIKH, A. J. GRODZINSKY, P. LIBBY, M. W. LARK & R. T. LEE. 1996. Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells. Circ. Res. 78: 44-49.
68. BENDECK, M. P., N. ZEMPO, A. W. CLOWES, R. E. GALARDY & M. A. REIDY. 1994. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res. 75: 539-545.
69. BENDECK, M. P., C. IRVIN & M. A. REIDY. 1996. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ. Res. 78: 38-43.
70. ZEMPO, N., N. KOYAMA, R. D. KENAGY, H. J. LEA & A. W. CLOWES. 1996. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler. Thromb. Vasc. Biol. 16: 28-33.
71. WELGUS, H. G., N. L. CONNOLLY & R. M. SENIOR. 1986. 12-o-Tetradecanoyl-phorbol-13-acetate-differentiated U937 cells express a macrophage-like profile of neutral proteinases: High levels of secreted collagenase and collagenase inhibitor accompany low levels of intracellular elastase and cathepsin G. J. Clin. Invest. 77: 1675-1681.
72. WELGUS, H. G., E. J. CAMPBELL, J. D. CURY, A. Z. EISEN, R. M. SENIOR, S. M. WILHELM & G. I. GOLDBERG. 1990. Neutral metalloproteinases produced by human mononuclear phagocytes: Enzyme profile, regulation, and expression during cellular development. J. Clin. Invest. 86: 1496-1502.
73. CAMPBELL, E. J., J. D. CURY, S. D. SHAPIRO, G. I. GOLDBERG & H. G. WELGUS. 1991. Neutral proteinases of human mononuclear phagocytes: Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J. Immunol. 146: 1286-1293.
74. PEARCE, W. H., I. SWEIS, J. S. YAO, W. J. MCCARTHY & A. E. KOCH. 1992. Interleukin-1 beta and tumor necrosis factor-alpha release in normal and diseased human infrarenal aortas. J. Vasc. Surg. 16: 784-789.
75. KOCH, A. E., S. L. KUNKEL, W. H. PEARCE, M. R. SHAH, D. PARIKH, H. L. EVANOFF, G. K. HAINES, M. D. BURDICK & R. M. STRIETER. 1993. Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am. J. Pathol. 142: 1423-1431.
76. NEWMAN, K. M., J. JEAN-CLAUDE, H. LI, W. G. RAMEY & M. D. TILSON. 1994. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 90(II): 224-227.
77. ROMANIC, A. M. & J. A. MADRI. 1994. The induction of 72 kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J. Cell Biol. 125: 1165-1178.
78. LACRAZ, S., P. ISLER, E. VEY, H. G. WELGUS & J. M. DAYER. 1994. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J. Biol. Chem. 269: 22027-22033.
79. SHAPIRO, S. D., E. J. CAMPBELL, D. K. KOBAYASHI & H. G. WELGUS. 1990. Immune modulation of metalloproteinase production in human macrophages: Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-γ. J. Clin. Invest. 86: 1204-1210.
80. 2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 267: 515-519.
81. SZEKANECZ, Z., M. R. SHAH, W. H. PEARCE & A. E. KOCH. 1994. Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but, not IL-2 and IL-4: The possible role for IL-6 and interferon-gamma in vascular inflammation. Agents Actions 42: 159-162.
82. HERRON, G. S., Z. WERB, K. DWYER & M. J. BANDA. 1986. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J. Biol. Chem. 261: 2810-2813.
83. POULSOM, R., M. PIGNATELLI, W. G. STETLER-STEVENSON, L. A. LIOTTA, P. A. WRIGHT, R. E. JEFFREY, J. M. LONGCROFT, L. ROGERS & G. W. STAMP. 1992. Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am. J. Pathol. 141: 389-396.
84. BROPHY, C. M., W. H. MARKS, J. M. REILLY & M. D. TILSON. 1991. Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: A preliminary report. J. Surg. Res. 50: 653-657.
85. TILSON, M. D., J. M. REILLY, C. M. BROPHY, E. L. WEBSTER & T. R. BARNETT. 1993. Expression and sequence of the gene for tissue inhibitor of metalloproteinases in patients with abdominal aortic aneurysms. J. Vasc. Surg. 18: 266-270.
86. MCGEEHAN, G. M., J. D. BECHERER, R. C. BAST, JR., C. M. BOYER, B. CHAMPION, K. M. CONNOLLY, J. G. CONWAY, P. FURDON, S. KARP, S. KIDAO, et al. 1994. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature 370: 558-561.
87. GEARING, A. J. H., P. BECKETT, M. CHRISTODOULOU, M. CHURCHILL, J. CLEMENTS, A. H. DAVIDSON, A. H. DRUMMOND, W. A. GALLOWAY, R. GILBERT, J. L. GORDON, et al. 1994. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370: 555-557.
88. MOHLER, K. M., P. R. SLEATH, J. N. FITZNER, D. P. CERETTI, M. ALDERON, S. S. KERWAR, D. S. TORRANCE, C. OTTEN-EVANS, T. GREENSTREET, K. WEERAWARNA, et al. 1994. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370: 218-220.
89. GREENWALD, R. A. & L. M. GOLUB, EDS. 1994. Inhibition of Matrix Metalloprotei-nases: Therapeutic Potential. Ann. N. Y. Acad. Sci. Vol. 732.
90. HALPERN, V. J., G. B. NACKMAN, R. H. GANDHI, E. IRIZARRY, J. V. SCHOLES, W. G. RAMEY & M. D. TILSON. 1994. The elastase infusion model of experimental aortic aneurysms: Synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response. J. Vasc. Surg. 20: 51-60.
91. THOMPSON, R. W., S. LIAO, D. PETRINEC, D. R. HOLMES, J. M. REILLY, H. G. WELGUS & W. C. PARKS. 1995. Sequential expression of metallogelatinases during elastase-induced aneurysmal degeneration of the rat aorta: Correlations with aortic dilatation and the destruction of medial elastin (abstract). FASEB J. 9: A967.
92. HOLMES, D. R., D. PETRINEC, W. WESTER, R. W. THOMPSON & J. M. REILLY. 1996. Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. J. Surg. Res. 63: 305-309.
93. PETRINEC, D., S. LIAO, D. R. HOLMES, J. M. REILLY, W. C. PARKS & R. W. THOMPSON. 1996. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: Preservation of aortic elastin associated with suppressed production of 92-kD gelatinase. J. Vasc. Surg. 23: 336-346.